The U.S. wound care centers market size is expected to reach USD 24.74 billion by 2033, registering a CAGR of 6.20% from 2026 to 2033, according to a new report by Grand View Research, Inc. The growth can be attributed to the growing prevalence of chronic wounds and rising awareness regarding wound care management. As per the Agency for Health Research and Quality (AHRQ), in the U.S., more than 2.5 million people suffer from pressure sores each year. In addition, according to the same source, pressure alone, or in combination with friction, results in Pressure Ulcers (PUs), which cost more than USD 11 billion annually in the U.S.
These centers provide care for various types of wounds, debridement of wounds with infections, HBOT for non-healing & chronic wounds, and specialized dressings. The centers are taking measures to make HBOT available to its patients, considering its effectiveness in healing chronic and non-healing wounds. Moreover, wound care centers benefit greatly from innovations in medical solutions for wound care treatment. For instance, UlceRx Therapy Solution Kit launched by SIGVARIS are compression stockings that assist centers in treating venous leg ulcers. Similarly, Healogics, Inc. organized an awareness campaign about the impact of heart health on wound healing, and nearly 82% of leg amputations in the U.S. need to be performed due to poor blood circulation in the limb, which can be avoided by compression therapy.
The COVID-19 pandemic adversely impacted the overall industry as many centers were closed and reduced patient volumes to curb the spread of the virus. After the initial disruptions caused by the pandemic, companies as well as the U.S. government began undertaking corrective actions to help the economy and businesses recover. To facilitate wound care during the COVID-19 pandemic, Healogics, Inc., a provider of wound care, launched its Telehealth Program, which was immediately made available to more than 600 wound care centers and 4,000 associated wound care providers.
Request a free sample copy or view report summary: U.S. Wound Care Centers Market Report
On the basis of procedure, the hyperbaric oxygen therapy segment held the largest revenue share of 31.13% in 2025 and is expected to grow at the fastest CAGR over the forecast period. Increasing awareness about the use of HBOT for chronic wounds, including diabetic foot ulcers, is expected to drive segment growth.
The debridement segment is expected to grow at a significant CAGR over the forecast period owing to its rising adoption for the treatment of diabetic foot ulcers.
Southeast region held a significant revenue share in 2025. Its dominance is driven by high prevalence of chronic diseases, particularly diabetes, obesity, and cardiovascular disorders, which are significantly higher in states such as Florida, Texas, Georgia, and North Carolina.
Grand View Research has segmented the U.S. wound care centers market on the basis of procedure, and region:
U.S. Wound Care Centers Procedure Outlook (Revenue, USD Billion, 2021 - 2033)
Debridement
Negative Pressure Wound Therapy
Compression Therapy
Hyperbaric Oxygen Therapy
Specialized Dressings
Infection Control & Others
U.S. Wound Care Centers Region Outlook (Revenue, USD Billion, 2021 - 2033)
Southeast
Midwest
West
Northeast
Southwest
List of Key Players of U.S. Wound Care Centers Market
Healogics, Inc.
TOWER WOUND CARE CENTER
Wound Care Center NYC
SNF Wound Care
WOUND INSTITUTE OF AMERICA
Schoolcraft Memorial Hospital
EmergeOrtho
Clarion Hospital
North Shore Health and Hyperbarics
Baptist Health South Florida
Natchitoches Regional Medical Center
"The quality of research they have done for us has been excellent..."